Whole-lung Lavage and Pulmonary Alveolar Proteinosis: Review of Clinical and Patient-centered Outcomes

被引:22
作者
Smith, Bradford B. [1 ]
Torres, Norman E. [1 ]
Hyder, Joseph A. [1 ]
Barbara, David W. [2 ]
Gillespie, Shane M. [1 ]
Wylam, Mark E. [3 ]
Smith, Mark M. [1 ]
机构
[1] Mayo Clin, Coll Med & Sci, Dept Anesthesiol & Perioperat Med, 200 First St SW, Rochester, MN 55905 USA
[2] Baycare Clin, Green Bay, WI USA
[3] Mayo Clin, Coll Med & Sci, Dept Pulmonol & Crit Care, Rochester, MN USA
关键词
whole lung lavage; pulmonary alveolar proteinosis; COLONY-STIMULATING FACTOR; EXTRACORPOREAL MEMBRANE-OXYGENATION; MANAGEMENT; SUPPORT;
D O I
10.1053/j.jvca.2019.03.047
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: The objective of this retrospective review was to evaluate the perioperative and procedural management of patients with pulmonary alveolar proteinosis (PAP) who presented for whole-lung lavage (WLL). Design: The records of all adult patients with PAP who underwent WLL between January 1, 1988 and August 20, 2017 were reviewed and pertinent demographic, preoperative, anesthetic, procedural, and postoperative data were recorded. Setting: Large academic tertiary referral center. Participants: Forty patients with PAP underwent 79 WLL procedures. Interventions: Patients with PAP undergoing WLL. Measurements: Successful WLL, defined by visual clearing of lavage fluid, was completed in 91% of cases. Whole-lung lavage was terminated prematurely in 9% of cases (refractory hypoxia most common), while 8% of cases were found to have 30-day complications. There were no cases of intraoperative death, hemodynamic collapse, pneumothorax or hydrothorax, or need for emergent reintubation. Postoperative clinical follow-up at the authors' institution within 6 months of WLL showed 68% of patients reported improvement in symptoms and/or functional status. Conclusion: The authors here present a retrospective study describing the perioperative and procedural management of PAP patients undergoing WLL to help familiarize providers with the management of this population (Fig 1). The findings of this study outline a successful and consistent approach to WLL using a multidisciplinary team experienced in this procedure. Even in experienced hands, procedural complications and 30-day postoperative complications emphasize the risk in this complex patient population. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:2453 / 2461
页数:9
相关论文
共 32 条
[1]   Therapeutic Whole-Lung Lavage for Pulmonary Alveolar Proteinosis A Procedural Update [J].
Abdelmalak, Basem B. ;
Khanna, Ashish K. ;
Culver, Daniel A. ;
Popovich, Marc J. .
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2015, 22 (03) :251-258
[2]   Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis [J].
Beccaria, M ;
Luisetti, M ;
Rodi, G ;
Corsico, A ;
Zoia, MC ;
Colato, S ;
Pochetti, P ;
Braschi, A ;
Pozzi, E ;
Cerveri, I .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (04) :526-531
[3]   Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures [J].
Campo, Ilaria ;
Luisetti, Maurizio ;
Griese, Matthias ;
Trapnell, Bruce C. ;
Bonella, Francesco ;
Grutters, Jan ;
Nakata, Koh ;
Van Moorsel, Coline H. M. ;
Costabel, Ulrich ;
Cottin, Vincent ;
Ichiwata, Toshio ;
Inoue, Yoshikazu ;
Braschi, Antonio ;
Bonizzoni, Giacomo ;
Iotti, Giorgio A. ;
Tinelli, Carmine ;
Rodi, Giuseppe .
ORPHANET JOURNAL OF RARE DISEASES, 2016, 11
[4]   Management of pulmonary alveolar proteinosis with whole lung lavage using extracorporeal membrane oxygenation support in a postrenal transplant patient with graft failure [J].
Chauhan, Sandeep ;
Sharma, Kamal P. ;
Bisoi, Akshay K. ;
Pangeni, Raju ;
Madan, Karan ;
Chauhan, Yogendra S. .
ANNALS OF CARDIAC ANAESTHESIA, 2016, 19 (02) :379-382
[5]   Pulmonary alveolar proteinosis - Treatment by bronchofiberscopic lobar lavage [J].
Cheng, SL ;
Chang, HT ;
Lau, HP ;
Lee, LN ;
Yang, PC .
CHEST, 2002, 122 (04) :1480-1485
[6]   Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF [J].
Gay, Pierre ;
Wallaert, Benoit ;
Nowak, Stefan ;
Yserbyt, Jonas ;
Anevlavis, Stavros ;
Hermant, Christophe ;
Lovis, Alban ;
Menard, Olivier ;
Maitre, Bernard ;
Vandemoortele, Thomas ;
Dutau, Herve ;
Briault, Amandine ;
Bourdin, Arnaud ;
Vergnon, Jean-Michel ;
Froudarakis, Marios E. .
RESPIRATION, 2017, 93 (03) :198-206
[7]   Whole-lung Lavage in a Patient with Pulmonary Alveolar Proteinosis [J].
Guevara, Lindsay R. Hunter ;
Gillespie, Shane M. ;
Klompas, Alan M. ;
Torres, Norman E. ;
Barbara, David W. .
ANNALS OF CARDIAC ANAESTHESIA, 2018, 21 (02) :215-217
[8]   New technologies in pediatric anesthesia [J].
Holtby, Helen ;
Skowno, Justin J. ;
Kor, Daryl J. ;
Flick, Randall P. ;
Uezono, Shoichi .
PEDIATRIC ANESTHESIA, 2012, 22 (10) :952-961
[9]   Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan [J].
Ishii, H. ;
Tazawa, R. ;
Kaneko, C. ;
Saraya, T. ;
Inoue, Y. ;
Hamano, E. ;
Kogure, Y. ;
Tomii, K. ;
Terada, M. ;
Takada, T. ;
Hojo, M. ;
Nishida, A. ;
Ichiwata, T. ;
Trapnell, B. C. ;
Goto, H. ;
Nakata, K. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) :465-468
[10]   An open-label trial of rituximab therapy in pulmonary alveolar proteinosis [J].
Kavuru, M. S. ;
Malur, A. ;
Marshall, I. ;
Barna, B. P. ;
Meziane, M. ;
Huizar, I. ;
Dalrymple, H. ;
Karnekar, R. ;
Thomassen, M. J. .
EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (06) :1361-1367